Indeed, tumour-infiltrating lymphocytes (TIL), particularly CD3 + CD8 + cells, have positive prognostic value in multiple cancers58–61 including ovarian cancers62, since they are involved in tumour antigen recognition and tumour killing. This evidence concerns the gene CD8A and neoplasm.